Nexgel Valuation
| NXGL Stock | USD 3.68 0.08 2.22% |
At this time, the firm appears to be undervalued. Nexgel Inc secures a last-minute Real Value of $4.75 per share. The latest price of the firm is $3.68. Our model forecasts the value of Nexgel Inc from analyzing the firm fundamentals such as Profit Margin of (0.68) %, current valuation of 26.65 M, and Return On Equity of -0.64 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Nexgel's price fluctuation is unstable at this time. Calculation of the real value of Nexgel Inc is based on 3 months time horizon. Increasing Nexgel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nexgel stock is determined by what a typical buyer is willing to pay for full or partial control of Nexgel Inc. Since Nexgel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nexgel Stock. However, Nexgel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.68 | Real 4.75 | Hype 3.69 | Naive 4.31 |
The intrinsic value of Nexgel's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nexgel's stock price.
Estimating the potential upside or downside of Nexgel Inc helps investors to forecast how Nexgel stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nexgel more accurately as focusing exclusively on Nexgel's fundamentals will not take into account other important factors: Nexgel Total Value Analysis
Nexgel Inc is now forecasted to have valuation of 26.65 M with market capitalization of 24.45 M, debt of 2.8 M, and cash on hands of 9.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nexgel fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
26.65 M | 24.45 M | 2.8 M | 9.79 M |
Nexgel Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.59. Nexgel Inc had not issued any dividends in recent years. The entity had 3:2 split on the 2nd of August 1990. Nexgel Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Nexgel Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nexgel has an asset utilization ratio of 41.07 percent. This suggests that the Company is making $0.41 for each dollar of assets. An increasing asset utilization means that Nexgel Inc is more efficient with each dollar of assets it utilizes for everyday operations.Nexgel Ownership Allocation
The market capitalization of Nexgel Inc is $24.45 Million. Nexgel Inc holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Nexgel Profitability Analysis
The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (3.16 M) with profit before overhead, payroll, taxes, and interest of 1.19 M.About Nexgel Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Nexgel Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nexgel Inc based exclusively on its fundamental and basic technical indicators. By analyzing Nexgel's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Nexgel's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nexgel. We calculate exposure to Nexgel's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nexgel's related companies.NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania. Nexgel operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Nexgel Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nexgel does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.7 M | |
| Forward Price Earnings | 59.8802 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.